The global Enzyme Replacement Therapy (ERT) market is poised for significant expansion, projected to reach USD 21.62 billion ...

According to FPT Digital, AI and generative AI are creating positive impacts across the global pharmaceutical industry. GenAI is expected to contribute between $60 billion and $110 billion annually ...

The drugmaker’s sales were up 7% at constant currency from the same period last year.

“The growth in Drug Management Agencies (DMAs) underscores this potential: from just six active DMAs in 2021, the number ...

Ascendis’ likely approval of TransCon CNP for achondroplasia poses a major threat to BioMarin’s best-selling drug. Read why I ...

Vertex Pharmaceuticals, under the leadership of CEO Reshma Kewalramani, was named in the “Impact Awards” category, which spotlights five standout companies making meaningful advancements in their ...

While Maryland remains a critical R&D hub for AstraZeneca, Virginia’s selection as the manufacturing cornerstone also highlights the state’s rising prominence in advanced pharmaceutical production, ...

Prescient Therapeutics (ASX: PTX) is fast emerging as the newest developer of an advanced cancer drug to meet a significant ...

The stock of Eli Lilly has a consensus Strong Buy rating among 19 Wall Street analysts. That rating is based on 16 Buy, two ...

Attorney General Alan Wilson announced approximately $720 million nationwide in settlements with eight drug makers that ...

Two months after laying off 20% of its staff, Korro Bio says it has not retreated from its “3-2-1” corporate strategy as it prepares to release interim clinical data on its lead candidate KRRO-110 in ...

Director Jeffrey S. Flier disclosed the sale of 11,136 shares of Scholar Rock(NASDAQ:SRRK) in an open market transaction. How does the transaction compare to previous insider activity?